Rafi Ahmed, Ph.D.
Area of Research: Basic
Immunology/Virology
As a basic immunologist, EVC Director Dr. Rafi Ahmed
studies immunological memory – the ability of the immune
system to “remember” a
particular antigen and respond accordingly. Dr. Ahmed and his
colleagues have made significant discoveries about how immune
memory cells are created and how long they survive; understanding
these mechanisms is crucial to the development of vaccines
for HIV and other infectious agents. In addition to contributing
vitally to vaccine science, Dr. Ahmed’s findings are
being applied to research into therapies for the treatment
of cancer and the prevention of organ rejection.
Dr. Ahmed holds
the title of Georgia Research Alliance Scholar in Vaccine
Research and is a Professor of Microbiology and Immunology
in the Emory University School of Medicine. He received his Ph.D. in microbiology
from Harvard University. Before coming to Emory in 1995, he
was a Professor in the Department of Microbiology and Immunology
at the University of California, Los Angeles School of Medicine.
Research
Understanding the intricacies of long-term immune
memory is a key to vaccine development. Rafi Ahmed, Director
of the Emory Vaccine Center and the Georgia Research Alliance
Eminent Scholar, is an internationally recognized expert on viral
persistence and the immune response to viruses. Dr. Ahmed and
his colleagues have made important discoveries about the differences
between the two types of immune memory -- humoral and cellular.
Dr. Ahmed has shown that plasma cells--the cells that produce
antibodies to prevent viral infection (humoral immunity)--live
for much longer than previously believed, perhaps even for the
entire life of an organism. His laboratory is now trying to uncover
the mechanisms that result in the generation of long-lived plasma
cells. Dr. Ahmed and his colleagues also have discovered that
CD8 T-cells--the cells that are activated by viral antigens--to
kill cells that are already infected (cellular immunity), respond
at their peak for only a few weeks, after which a small percentage
become memory cells capable of mounting a stronger and more rapid
immune response if reintroduced to the original virus. Studies
to elucidate the molecular basis of T-cell memory are being pursued
in the laboratory. The long-term goal of Dr. Ahmed's research
is to understand the mechanisms of immunological memory and to
use this information to develop new vaccines for the prevention
and treatment o f disease.

Bio
Publications
Grants
|